Dual-Energy CT in Oncologic Imaging

Giovanni Foti,Giorgio Ascenti,Andrea Agostini,Chiara Longo,Fabio Lombardo,Alessandro Inno,Alessandra Modena,Stefania Gori
DOI: https://doi.org/10.3390/tomography10030024
2024-02-23
Tomography
Abstract:Dual-energy CT (DECT) is an innovative technology that is increasingly widespread in clinical practice. DECT allows for tissue characterization beyond that of conventional CT as imaging is performed using different energy spectra that can help differentiate tissues based on their specific attenuation properties at different X-ray energies. The most employed post-processing applications of DECT include virtual monoenergetic images (VMIs), iodine density maps, virtual non-contrast images (VNC), and virtual non-calcium (VNCa) for bone marrow edema (BME) detection. The diverse array of images obtained through DECT acquisitions offers numerous benefits, including enhanced lesion detection and characterization, precise determination of material composition, decreased iodine dose, and reduced artifacts. These versatile applications play an increasingly significant role in tumor assessment and oncologic imaging, encompassing the diagnosis of primary tumors, local and metastatic staging, post-therapy evaluation, and complication management. This article provides a comprehensive review of the principal applications and post-processing techniques of DECT, with a specific focus on its utility in managing oncologic patients.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?
The paper aims to explore the application and advantages of Dual-Energy CT (DECT) in tumor imaging. Specifically, the paper focuses on addressing the following issues: 1. **Enhanced Tissue Characterization**: DECT can better differentiate various tissues by using different energy spectra for imaging, especially based on their specific attenuation characteristics at different X-ray energies. 2. **Application of Multiple Post-Processing Techniques**: DECT provides multiple post-processing techniques, including Virtual Monoenergetic Images (VMIs), iodine density maps, Virtual Non-Contrast Images (VNC), and Virtual Non-Calcium Images (VNCa). These techniques help enhance lesion detection and characterization, accurately determine material composition, and reduce iodine dose and artifacts. 3. **Tumor Assessment and Management**: DECT plays an important role in tumor assessment and management, covering primary tumor diagnosis, local and distant metastasis staging, postoperative evaluation, and complication management. 4. **Specific Application Scenarios**: - **Renal Imaging**: VNC technology can help distinguish between benign and malignant renal lesions, especially for the evaluation of cystic lesions. - **Adrenal Lesion Assessment**: VNC technology can be used to assess incidental adrenal findings, such as differentiating adenomas from metastases and calculating washout curves. - **Vascular Imaging**: VNC technology allows for the assessment of vascular calcification without the need for additional non-contrast scans and helps identify vascular pathologies such as aneurysms, dissections, or thrombosis. - **Bleeding Assessment**: VNC technology combined with iodine density maps can be used to diagnose complications such as gastrointestinal bleeding. 5. **Application of Iodine Density Maps**: Iodine density maps can effectively highlight the vascularity of tissues, particularly in hepatocellular carcinoma and other highly vascularized tumors. Additionally, iodine density maps can be used to evaluate the efficacy of chemoembolization. In summary, this paper provides a comprehensive review of the main applications of DECT and its post-processing techniques, with a particular emphasis on its significant contributions to the management of tumor patients.